Skip to content

Clinical trials

Completed Insulin Resistance trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Status: Completed Country / region: Japan Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20071
20081
20094
20102
20112
20145

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanabe Pharma Corporation10
Sanwa Kagaku Kenkyusho Co., Ltd.3
Eli Lilly and Company2
Tottori University Hospital2
Astellas Pharma Inc1
Sanofi1
Tokyo Study Group1
Toujinkai Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance21
Diabetes Mellitus, Type 216
Coronary Artery Disease1
Death1
Diabetes Mellitus1
Diabetes Mellitus, Type 11
Disease Progression1
Heart Failure1
Hyperglycemia1
Hypertension1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.